Treating Gonococcal Pharyngitis in Pregnancy and Breast/Chest Feeding (Lactation)
Gonococcal pharyngitis during pregnancy or the breast/chest feeding period requires a carefully considered treatment selection, as this patient population significantly narrows the range of appropriate antimicrobial options.
This protocol applies to individuals with gonococcal pharyngitis who are pregnant or currently breast/chest feeding (lactating). Quinolones must not be used in this setting, and gentamicin is contraindicated in pregnancy — these exclusions shape every treatment decision.
Management centres on an injectable antibiotic regimen; notably, pregnancy does not diminish treatment efficacy. The full protocol — including the structured decision criteria, any applicable alternatives, and sequencing — is available via the link below.
The aim is resolution of pharyngeal infection, confirmed by a negative test of cure. A test of cure using NAAT is required after treatment, with specific timing requirements detailed in the full protocol.
References
DOI: 10.1177/09564624251345195
- Pregnant and breast/chest-feeding individuals should not be treated with quinolones.
- Gentamicin should be avoided in pregnancy.
- Ceftriaxone 1 g intramuscularly (IM) as a single dose (GRADE 1B).
- Pregnancy does not diminish treatment efficacy.
- Those with pharyngeal infection should be negative 12 days following treatment.
- We recommend TOC using NAAT should be performed at least two weeks after treatment (GRADE 1B).